Quantitative dynamic MRI and localisation of non-palpable prostate cancer;IRM dynamique quantitative et localisation du cancer de prostate non palpable

Progres en Urologie

Volumn 19, Issue 6, 2009, Pages 401-413

  Cornud, F ^a   Beuvon, F ^a   Thevenin F ^a   Chauveinc, L ^b   Vieillefond, A ^a   Descazeaux, A ^a   Flam, T ^a  

^a hôpital Cochin ^*  (France)

^b clinique Hartmann   (France)

Author keywords

Localisation; Prostate cancer; Quantitative dynamic contrast; Tumor volume

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

AGED; ARTICLE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSTATE; PROSTATE TUMOR;

AGED; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS;

EID: 65749109136     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2009.01.007     Document Type: Article

References (35)

1. Cornud F., Flam T., Chauveinc L., Hamida K., Chretien Y., Vieillefond A., et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology 224 (2002) 203-210
2. Amsellem-Ouazana D., Younes P., Conquy S., Peyromaure M., Flam T., Debre B., et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur Urol 47 (2005) 582-586
3. Costouros N.G., Coakley F.V., Westphalen A.C., Qayyum A., Yeh B.M., Joe B.N., et al. Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging. Am J Roentgenol 188 (2007) 812-816
4. Prando A., Kurhanewicz J., Borges A.P., Oliveira Jr. E.M., and Figueiredo E. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 236 (2005) 903-910
5. Boccon-Gibod L.M., de Longchamps N.B., Toublanc M., Boccon-Gibod L.A., and Ravery V. Prostate saturation biopsy in the reevaluation of microfocal prostate cancer. J Urol 176 (2006) 961-963 (discussion 963-4)
6. Ravery V., Dominique S., Panhard X., Toublanc M., and Boccon-Gibod L. The 20-core prostate biopsy protocol - a new gold standard?. J Urol 179 (2008) 504-507
7. Dall'Era M.A., Konety B.R., Cowan J.E., Shinohara K., Stauf F., Cooperberg M.R., et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 112 (2008) 2664-2670
8. Polascik T.J., and Mouraviev V. Focal therapy for prostate cancer. Curr Opin Urol 18 (2008) 269-274
9. Mullerad M., Hricak H., Kuroiwa K., Pucar D., Chen H.N., Kattan M.W., et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 174 (2005) 2158-2163
10. Ravery V., Szabo J., Toublanc M., Boccon-Gibod L.A., Billebaud T., Hermieu J.F., et al. A single positive prostate biopsy in six does not predict a low-volume prostate tumour. Br J Urol 77 (1996) 724-728
11. Hricak H., Choyke P.L., Eberhardt S.C., Leibel S.A., and Scardino P.T. Imaging prostate cancer: a multidisciplinary perspective. Radiology 243 (2007) 28-53
12. Cornud F., Hamida K., Flam T., Helenon O., Chretien Y., Thiounn N., et al. Endorectal color Doppler sonography and endorectal MR imaging features of non-palpable prostate cancer: correlation with radical prostatectomy findings. AJR Am J Roentgenol 175 (2000) 1161-1168
13. Choi Y.J., Kim J.K., Kim N., Kim K.W., Choi E.K., and Cho K.S. Functional MR imaging of prostate cancer. Radiographics 27 (2007) 63-75 (discussion 75-77)
14. Girouin N., Mege-Lechevallier F., Tonina Senes A., Bissery A., Rabilloud M., Marechal J.M., et al. Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?. Eur Radiol 17 (2007) 1498-1509
15. Villers A., Puech P., Mouton D., Leroy X., Ballereau C., and Lemaitre L. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 176 (2006) 2432-2437
16. Padhani A.R., Gapinski C.J., Macvicar D.A., Parker G.J., Suckling J., Revell P.B., et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55 (2000) 99-109
17. Padhani A.R., and Husband J.E. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 56 (2001) 607-620
18. D'Amico A.V., Whittington R., Malkowicz S.B., Schultz D., Fondurulia J., Chen M.H., et al. Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer [see comments]. J Clin Oncol 18 (2000) 1164-1172
19. Qayyum A., Coakley F.V., Lu Y., Olpin J.D., Wu L., Yeh B.M., et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. Am J Roentgenol 183 (2004) 1079-1083
20. Tofts P.S., Brix G., Buckley D.L., Evelhoch J.L., Henderson E., Knopp M.V., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10 (1999) 223-232
21. Akin O., Sala E., Moskowitz C.S., Kuroiwa K., Ishill N.M., Pucar D., et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 239 (2006) 784-792
22. Chen M.E., Johnston D., Reyes A.O., Soto C.P., Babaian R.J., and Troncoso P. A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume. Am J Surg Pathol 27 (2003) 1291-1301
23. Coakley F.V., Kurhanewicz J., Lu Y., Jones K.D., Swanson M.G., Chang S.D., et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 223 (2002) 91-97
24. Kiessling F., Lichy M., Grobholz R., Heilmann M., Farhan N., Michel M.S., et al. Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI. Eur Radiol 14 (2004) 1793-1801
25. Schlemmer H.P., Merkle J., Grobholz R., Jaeger T., Michel M.S., Werner A., et al. Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?. Eur Radiol 14 (2004) 309-317
26. Futterer J.J., Heijmink S.W., Scheenen T.W., Veltman J., Huisman H.J., Vos P., et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241 (2006) 449-458
27. van Dorsten F.A., van der Graaf M., Engelbrecht M.R., van Leenders G.J., Verhofstad A., Rijpkema M., et al. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 20 (2004) 279-287
28. Ocak I., Bernardo M., Metzger G., Barrett T., Pinto P., Albert P.S., et al. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. Am J Roentgenol 189 (2007) W192-W201
29. Kurhanewicz J., Vigneron D., Carroll P., and Coakley F. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol 18 (2008) 71-77
30. Turnbull L.W., Buckley D.L., Turnbull L.S., Liney G.P., and Knowles A.J. Differentiation of prostatic carcinoma and benign prostatic hyperplasia: correlation between dynamic Gd-DTPA-enhanced MR imaging and histopathology. J Magn Reson Imaging 9 (1999) 311-316
31. Kirkham A.P., Emberton M., and Allen C. How good is MRI at detecting and characterising cancer within the prostate?. Eur Urol 50 (2006) 1163-1174 discussion 1175
32. Jager G.J., Ruijter E.T., van de Kaa C.A., de la Rosette J.J., Oosterhof G.O., Thornbury J.R., et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol 166 (1996) 845-852
33. Ponchietti R., Di Loro F., Fanfani A., and Amorosi A. Estimation of prostate cancer volume by endorectal coil magnetic resonance imaging vs. pathologic volume. Eur Urol 35 (1999) 32-35
34. de Bazelaire C.M.J., Duhamel G.D., Rofsky N.M., and Alsop D.C. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 230 (2004) 652-659
35. Pabst T., Kenn W., Kaiser W.A., and Hahn D. Understanding why contrast enhancement in dynamic MRI is not reproducible: illustration with a simple phantom. Breast J 7 (2001) 166-170